Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood Test Differentiates Bacterial and Viral Infections in Febrile Infants

By LabMedica International staff writers
Posted on 29 Sep 2026

Fever in infants younger than 3 months is treated as a medical emergency because infections can become life-threatening while the immune system is still developing. More...

Emergency department teams must quickly distinguish serious bacterial infections that require antibiotics from viral illnesses that usually need monitoring and supportive care. To support this early differentiation, a new blood test uses paired immune-cell markers to help distinguish bacterial from viral infection in febrile newborns.

The investigational test compares the blood levels of CD64 and CD169, two molecules that rise in response to different infection types. CD64 is found on neutrophils, a type of white blood cell, and is thought to increase in bacterial infection. CD169 is found on monocytes, another type of white blood cell, and is thought to increase in viral infection.

Researchers tested blood samples from 60 babies brought to the pediatric emergency department at IRCCS Istituto Giannina Gaslini in Genoa, Italy. Some infants were being assessed and treated for fever, while others were being evaluated for noninfectious conditions. The samples were analyzed using flow cytometry, which enables assessment of individual cell characteristics.

The researchers combined CD64 and CD169 measurements into a ratio for each baby. The average ratio was 1.10 in babies with no infection, 0.33 in babies ultimately confirmed to have a viral infection, and 16.22 in babies confirmed to have a bacterial infection. The test showed 100% sensitivity for bacterial infection and 96.6% specificity, indicating that false positives were very low in this initial cohort.

The research is continuing and is expected to include data on 75 babies. A larger multicenter prospective study, called DISCERN, or Discriminating Infection via Surface CD-marker Expression Ratios iN infancy, is also beginning. That study will assess test accuracy in 300 to 500 babies.

“In very young babies with fever, distinguishing serious bacterial infection from self-limiting viral illness is a major diagnostic dilemma. Our standard biomarkers can help show when there might be a bacterial infection, but they also create 'false positives,' which drives overtreatment. This can mean unnecessary lumbar punctures, antibiotics and hospital admissions for infants who turn out to have only a virus,” said Dr. Tommaso Bellini, pediatric emergency physician at the IRCCS Istituto Giannina Gaslini.

Related Links
IRCCS Istituto Giannina Gaslini


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Nucleic Acid Purification Instrument
QIAsymphony Connect
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Dr. Maria “Ken” Figueroa is investigating how epigenetics can inform treatment paths for cancer patients. (Image Credit: Sylvester Comprehensive Cancer Center)

DNA Methylation May Predict Treatment Response in Myelodysplastic Syndromes

Myelodysplastic syndromes (MDS) are disorders in which the bone marrow does not produce healthy blood cells normally. Treatment selection can be challenging because clinicians cannot reliably predict which... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: Siemens Healthineers has begun carving out its in vitro diagnostics business as a standalone company named Olyrian Diagnostics (Photo courtesy of Siemens Healthineers)

Siemens Healthineers Begins Transition Toward Standalone Olyrian Diagnostics Business

Siemens Healthineers has begun carving out its in vitro diagnostics business, which will operate as Olyrian Diagnostics. The new name will be introduced in stages as the business prepares to become a standalone... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.